← Leaderboards
Emily J Tsai
Temple Univ Of The Commonwealth
$4,514,817
Attributed
$4,514,817
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $662.8K · FY2012–25$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,514,817 · 4
By mechanism
R01$2,671,452 · 1
P01$980,420 · 1
K08$702,945 · 1
R03$160,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Temple Univ Of The Commonwealth
Same institution · by research overlap
- Xiongwen Chen$5,997,234
- Salvatore Mancarella$2,585,775
- Shavonn Christine Harper$64,125
- Erhe Gao$3,231,475
- Suresh K Verma$2,436,392
Others in their field
Top investigators on “Stress”
- Chanza Baytop · Westat, Inc.$271,217,917
- Judith S Hochman · New York University School Of Medicine$109,572,916
- James E. Gern · University Of Wisconsin-Madison$100,351,848
- Sharon A Nachman · Johns Hopkins University$74,725,055
- Robert O Wright · Brigham And Women'S Hospital$71,259,719
- Leonardo Trasande · New York University School Of Medicine$59,472,515
Research focus
StressCardiacCouplingRegulationHeart FailurePhysiologicalSignal TransductionPressureCardiac MyocytesPathologicResearch PersonnelPhysiologyIn VitroPreventMolecularMediatingHeartSoluble Guanylate CyclaseCyclic GmpMyocardialHypertrophyMouse ModelIn VivoInsight
Grant awards (15)
Mouse Cardiac Physiology Core$329,000
P01 · FY2025 · HL · contact PI
Mouse Cardiac Physiology Core$322,420
P01 · FY2024 · HL · contact PI
Mouse Cardiac Physiology Core$329,000
P01 · FY2023 · HL · contact PI
Novel Cardioprotective sGC/cGMP Microdomains: Therapeutic Targets in Medically Treated HF$496,453
R01 · FY2021 · HL · contact PI
Novel Cardioprotective sGC/cGMP Microdomains: Therapeutic Targets in Medically Treated HF$520,453
R01 · FY2020 · HL · contact PI
Novel Cardioprotective sGC/cGMP Microdomains: Therapeutic Targets in Medically Treated HF$520,453
R01 · FY2019 · HL · contact PI
Novel Cardioprotective sGC/cGMP Microdomains: Therapeutic Targets in Medically Treated HF$551,273
R01 · FY2018 · HL · contact PI
Novel Cardioprotective sGC/cGMP Microdomains: Therapeutic Targets in Medically Treated HF$582,820
R01 · FY2017 · HL · contact PI
Therapeutic Potential of Myocardial Soluble Guanylyl Cyclase Signaling in Right Ventricular Dysfunction$80,000
R03 · FY2017 · HL · contact PI
Functional Implications of Caveolae-Localized Myocardial sGC in Heart Failure$164,268
K08 · FY2016 · HL · contact PI
Therapeutic Potential of Myocardial Soluble Guanylyl Cyclase Signaling in Right Ventricular Dysfunction$80,000
R03 · FY2016 · HL · contact PI
Functional Implications of Caveolae-Localized Myocardial sGC in Heart Failure$130,842
K08 · FY2015 · HL · contact PI
Functional Implications of Caveolae-localized Myocardial sGC in Heart Failure$135,945
K08 · FY2014 · HL · contact PI
Functional Implications of Caveolae-localized Myocardial sGC in Heart Failure$135,945
K08 · FY2013 · HL · contact PI
Functional Implications of Caveolae-localized Myocardial sGC in Heart Failure$135,945
K08 · FY2012 · HL · contact PI